š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
Influenza virus is a significant pathogen in pediatric solid organ transpla...
Status
Recruiting
Location
Stanford University
Start Date
2024-09-26
Trial ID
NCT05947071
Lung allograft recipients have a higher burden of influenza disease and gre...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2022-11-08
Trial ID
NCT05215327
The main purpose of this Phase II study was to assess the safety and immuno...
Status
Completed
Location
Investigational Site Number :8400003
Start Date
2021-07-16
Trial ID
NCT04969276
Treatments Being Tested
In solid organ transplant (SOT) the receipt of influenza vaccine in an infl...
Status
Completed
Location
University of Minnesota
Start Date
2023-09-11
Trial ID
NCT05663463
Treatments Being Tested
The purpose of this study is to evaluate Immunogenicity and Safety of a Hig...
Status
Completed
Location
CenExel CNS- Site Number : 8400005
Start Date
2024-11-04
Trial ID
NCT06641180
The overall aim of the study is to compare safety and immunogenicity of ina...
Status
Completed
Location
Centers for Disease Control and Prevention
Start Date
2017-08-28
Trial ID
NCT03183908
Treatments Being Tested
Hypothesis 1: The safety profile in adult allogeneic stem cell hematopoieti...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center, Clinical Trials Information Program
Start Date
2010-10
Trial ID
NCT01215734
This pilot research trial studies the antibody response to high-dose season...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2017-10-17
Trial ID
NCT04484532
Treatments Being Tested
This is a Phase I, first-in-human, randomized, modified double-blind, activ...
Status
Completed
Location
AES - DRS - Optimal Research_Site 8400007
Start Date
2022-06-09
Trial ID
NCT05426174
Treatments Being Tested